 | Up a level |
Stucki, A; Cottagnoud, M; Acosta, F; Egerman, U; Laeuffer, JM; Cottagnoud, P (2012). Efficacy of doripenem against escherichia coli and klebsiella pneumoniae in experimental meningitis. Journal of antimicrobial chemotherapy, 67((3)), pp. 661-5. Oxford: Oxford University Press 10.1093/jac/dkr482
Egermann, U; Stanga, Z; Ramin, A; Acosta, F; Stucki, A; Gerber, P; Cottagnoud, M; Cottagnoud, Ph (2009). Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrobial agents and chemotherapy, 53(7), pp. 3030-3. Washington, D.C.: American Society for Microbiology 10.1128/AAC.00952-08
Cottagnoud, P; Gerber, CM; Majcherczyk, PA; Acosta, F; Cottagnoud, M; Neftel, K; Moreillon, P; Täuber, MG (2003). The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis. Infection and immunity, 71(6), pp. 3663-6. New York, N.Y.: American Society for Microbiology 10.1128/IAI.71.6.3663-3666.2003
Cottagnoud, P; Pfister, M; Cottagnoud, M; Acosta, F; Täuber, MG (2003). Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 47(6), pp. 1943-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.47.6.1943-1947.2003
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(5), pp. 1607-9. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.5.1607-1609-2002
Cottagnoud, P; Acosta, F; Cottagnoud, M; Täuber, MG (2002). Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis. Journal of antimicrobial chemotherapy, 49(2), pp. 327-30. Oxford: Oxford University Press 10.1093/jac/49.2.327
Cottagnoud, P; Acosta, F; Cottagnoud, M; Pfister, M; Täuber, MG (2002). Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis. Antimicrobial agents and chemotherapy, 46(1), pp. 184-7. Washington, D.C.: American Society for Microbiology 10.1128/AAC.46.1.184-187.2002
Perrig, M; Acosta, F; Cottagnoud, M; Gerber, CM; Täuber, MG; Cottagnoud, P (2001). Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. Journal of antimicrobial chemotherapy, 47(5), pp. 701-4. Oxford: Oxford University Press 10.1093/jac/47.5.701
Cottagnoud, P; Gerber, CM; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model. Journal of antimicrobial chemotherapy, 46(6), pp. 981-5. Oxford: Oxford University Press 10.1093/jac/46.6.981
Cottagnoud, P; Acosta, F; Cottagnoud, M; Neftel, K; Täuber, MG (2000). Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrobial agents and chemotherapy, 44(8), pp. 2179-81. Washington, D.C.: American Society for Microbiology 10.1128/AAC.44.8.2179-2181.2000
